Ege David S.
Officer at MCRB
- Sold, on record
- $89k
- Dollars the filings state
- Form 4 sales
- 6
- Latest Aug 16, 2024
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- MCRBSeres Therapeutics, Inc.Officer
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale MCRBPlan not statedOct 31 2022
Sold 5,012 shares at $7.93 ($40k)
Ege David S., Officer
Sold 9.7% of holdings ($410k position)46,734 shares leftFirst sale on recordFiling
- 2 Form 4 sale MCRBNo planApr 28 +179 days
Sold 7,038 shares at $5.19 ($37k)
Ege David S., Officer
No 10b5-1 planSold 10.5% of holdings ($346k position)59,696 shares leftFiling
- 3 Form 4 sale MCRBRoutineOct 30 +185 days
Sold 4,066 shares at $1.35 ($5k)
Ege David S., Officer
10b5-1 planSold 5.7% of holdings ($96k position)66,991 shares leftFiling
- 4 Form 4 sale MCRBRoutineFeb 16 +109 days
Sold 5,010 shares at $1.08 ($5k)
Ege David S., Officer
10b5-1 planSold 6.4% of holdings ($85k position)73,856 shares left1x usual sizeFiling
- 5 Form 4 sale MCRBRoutineMay 15 +89 days
Sold 1,090 shares at $0.94 ($1k)
Ege David S., Officer
10b5-1 planSold 1.4% of holdings ($72k position)75,734 shares left0.2x usual sizeFiling
- 6 Form 4 sale MCRBRoutineAug 16 +93 days
Sold 1,128 shares at $0.84 ($948)
Ege David S., Officer
10b5-1 planSold 1.4% of holdings ($66k position)77,575 shares left0.2x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (6)
| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| Aug 16, 2024 | MCRB | Officer | Form 4 sale | 1,128 | $948 | 1.4% | Routine | SEC |
| May 15, 2024 | MCRB | Officer | Form 4 sale | 1,090 | $1k | 1.4% | Routine | SEC |
| Feb 16, 2024 | MCRB | Officer | Form 4 sale | 5,010 | $5k | 6.4% | Routine | SEC |
| Oct 30, 2023 | MCRB | Officer | Form 4 sale | 4,066 | $5k | 5.7% | Routine | SEC |
| Apr 28, 2023 | MCRB | Officer | Form 4 sale | 7,038 | $37k | 10.5% | No plan | SEC |
| Oct 31, 2022 | MCRB | Officer | Form 4 sale | 5,012 | $40k | 9.7% | Plan not stated | SEC |